LUMIGAN 0.3 mg / ml eye drops areonto the Sterile
1 m1. solution; Contains 0.3 mg bimatoprost as active ingredient.
985 Item Items
Warning: Last items in stock!
|2||5%||Up to $3.40|
|3||10%||Up to $10.20|
|4||15%||Up to $20.40|
|5||20%||Up to $34.00|
Contains benzalkonium chloride as preservative and sodium phosphate dibasic heptahydrate, citric acid monohydrate, sodium chloride, sufficient amount of hydrochloric acid and sodium hydroxide (for pH adjustment) and pure water as
preservatives. contains important information for you.
Keep these instructions for use. You can need to read again.
• If you have other questions, please talk your doctor or pharmacist.
• This medication has been prescribed for you personally, do not give it to others.
• When using this medicine, tell your doctor that you are using this medicine when you go to the doctor or hospital.
• Follow exactly what is written in this instruction. Doother than the recommended dose for the high or low dosesdrug not use.
In this leaflet:
1. What is LUMIGAN and what is it used for?
2. Things to consider before using LUMIGAN
3. How to use LUMIGAN?
4. What are the possible side effects?
5. LUMIGAN hiding
Headlines are included.
LUMIGAN is an antiglaucoma drug. It belongs to a group of drugs called prostamids.
LUMIGAN eye drops are used to lower the high pressure in the eye. This high pressure can lead to a disease called glaucoma. If the high pressure cannot be reduced, it may eventually impair your vision.
Your eye contains a clear, water-like liquid that nourishes the inside of the eye. This fluid is constantly emptied out of the eye and replaced by the newly made fluid. If the fluid is not drained out quickly enough, the pressure inside the eye will increase. LUMIGAN works by increasing the amount of fluid discharged. This reduces the pressure in the eye.
LUMIGAN can be used alone or in combination with other drops called beta-blockers, which reduce intraocular pressure.
administration In treatments given alone or in combination with other drugs that lower eye pressure,a single drop to the patient's eye once a day in the evening.
To prevent contamination of the dropper tip and solution, care should be taken that the dropper tip of the bottle does not touch the eyelids, around the periphery or other surfaces. The bottle should be kept tightly closed, unless using it.
If more than one topical ophthalmic drug is used, the drugs should be applied at least 5 minutes apart.
Lumigan should not be usedunder 18 years of age.
elderly There is no need for any dosage adjustment in elderly patients.
Kidney / Liver failure:
Use LUMIGAN cautiously if you have these conditions, since they have not been studied in patients with liver or kidney failure.
If you have an impression that the effect of LUMIGAN is too strong or weak, talk to your doctor or pharmacist.
talk to a doctor or pharmacist if you have used LUMIGAN more than you should.
the the taketime.
Do not take a double dose toforgotten dose.
LUMIGAN is terminated. There is noLUMIGAN is terminated.
Like all medicines, LUMIGAN may have side effects in people who are sensitive to the substances in its content.
if one of the following, please stop using the lumigan tell your doctor or yourto the emergency department of the nearest
handshospital,feet, ankles, face, lips swollen or particularly oral ingestion or the swelling that makes it difficult to breathe.
These are all very serious side effects.
If you have one of these, you have a serious allergy to LUMIGAN. You may need an emergency medical intervention or hospitalization.
All of these very serious side effects are very rare.
Tell your doctor if you notice any of the following:
Most often, redness in the eyes, itching, lashes, darkening of the lashes, inflammation of the eyelid, swelling, redness, itching, foreign body sensation,eye color
change in, eye irritation, sensitivity to light, dry eye. , skin color around the eyes, tears, visual impairment, worsening of visual acuity, eyelid contraction, headache, increased body hairiness, impaired liver laboratory tests, weakness, upper respiratory tract infection, depression, dizziness. These are mild side effects of LUMIGAN.
Very common side effects:affect
These canone or more of every 10 users.
• Eyelash growth (up 45%)
• Lightweight girlarclimate (up 44%)
• Itching (up to 14%)
Common side effects:
these may affect one to nine people in every 100 users.
Effects on the eye:
• Allergic reaction in the
eye • Eye fatigue
• Sensitivity to light
• Color darkening on the skin around the eye
• Darkness in the color of the eyelashes
• Feeling of foreign body in the
eyeStickiness in the eyes • Darkness in the
• Difficulty seeing clearly
• Inflamed, red and itchy eyelids
• Dryness • Blistering on the
eye-helping layer covering the eye surface
• Small cracks with or without inflammation on the eye surface
Effects on the body:
• Increased results of blood tests of your liverIncreased
Uncommon side effects:
These it can affect one to nine people per 1000 users.
• cystoid macular edema (swelling of causing deterioration in vision in the retina of the eye)
• Inflammation within the eye
if you have an allergy to any of the ingredients in theIfdrug compoundscases,do not use ..
• If you have liver or kidney problems,
• if you have had previous cataract surgery, tell your doctor.
During treatment with LUMIGAN there may be permanent changes in eye color, eyelid skin and eyelashes. There may also be an increase in the number and / or length of the lashes (there may be a difference between the eyes). If you have another inflammatory disease in your eyes, use with caution.
Since LUMIGAN contains benzalkonium chloride as a preservative, contact lenses should not be applied while in the eyes, as contact lenses can absorb benzalkonium chloride. Contact lenses must be removed and reinserted 15 minutes after administration of the drug before LUMIGAN is used.
Do not use Lumigan under the age of 18.
If these warnings are valid for you, even at any time in the past, please consult your doctor.
Consult your doctor or pharmacist beforemedicine.
The use of the drug should be decided by the physician by evaluating the risk / benefit ratio. Otherwise, it should not be used during pregnancy.
If you notice that you are pregnant during your treatment, consult your doctor or pharmacist immediately.
Consult your doctor or pharmacist before usingMedicine.
Bimatoprost can pass into breast milk. It is recommended that LUMIGAN should not be used in nursing mothers.
As with all ocular medications, there may be a temporary blurring when medication is given. Wait until your vision becomes clear before you start driving or using machines.
It contains benzalkonium chloride as preservativecontent gdinz may cause irritation. Yumaevilcontactwithflowscontact lensifrom thekdniniz.the application dof contact lenses n threeacardinizand attach the lens idin at leastiWait forn15 minutes. Yumatheevilakacontactdeterioration of the color of the lensiwas causednağu are known.
No drug interaction has been reported in the application by instillation. If you are using more than one eye drops, apply the drugs at least 5 minutes apart.
LUMIGANLUMIGAN in places where children cannot see, cannot reach, and in its packaging
It should be stored at room temperature below 25 ° C.
It should be used within 4 weeks after the first opening.
Use in accordance with expiration dates.
Do not use LUMIGAN after the expiration date on the packaging.
Posology / frequency and duration of application: When
used in monotherapy or adjuvant therapy, the recommended dose is LUMIGAN once daily in the evening to the affected eyes / s. The dose should not exceed once a day as more frequent administration may reduce the intraocular pressure lowering effect.
administrationIf more than one topical ophthalmic drug is used, the drugs should be applied at least 5 minutes apart.
Care should be taken that the dropper tip does not touch the eyelids, perimeter, or other surfaces of the bottle to prevent contamination of the dropper tip and solution. The bottle should be kept tightly closed, unless using it.
Additional information on special populations: Kidney / Liver failure Notwith
tested in patientsrenal or hepatic impairment. Therefore, it should be used with caution in these patients.
Pediatric population: The
efficacy and safety of pediatric patients have not been established. LUMIGAN should not be used in patients under 18 years of age.